doi: 10.1056/NEJMp1314078.
Pancreatic safety of incretin-based drugs--FDA and EMA assessment
Affiliations
- PMID: 24571751
- DOI: 10.1056/NEJMp1314078
Item in Clipboard
Pancreatic safety of incretin-based drugs--FDA and EMA assessment
N Engl J Med.
.
Free article
Erratum in
- N Engl J Med. 2014 Jun 5;370(23):2253
No abstract available
Similar articles
-
Potential harms of type 2 diabetes drugs have been ignored, finds BMJ investigation.BMJ. 2013 Jun 11;346:f3782. doi: 10.1136/bmj.f3782. BMJ. 2013. PMID: 23757752 No abstract available.
-
FDA is to assess data linking type 2 diabetes drugs with pancreatitis.BMJ. 2013 Mar 19;346:f1808. doi: 10.1136/bmj.f1808. BMJ. 2013. PMID: 23512765 No abstract available.
-
Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan.Pancreatology. 2017 Jan-Feb;17(1):76-82. doi: 10.1016/j.pan.2016.10.003. Epub 2016 Oct 7. Pancreatology. 2017. PMID: 27743712
-
[Incretin-based antidiabetic treatment and diseases of the pancreas (pancreatitis, pancreas carcinoma)].Orv Hetil. 2016 Apr 3;157(14):523-8. doi: 10.1556/650.2016.30409. Orv Hetil. 2016. PMID: 27017851 Review. Hungarian.
-
Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?Expert Opin Drug Saf. 2014 Nov;13(11):1469-81. doi: 10.1517/14740338.2014.955013. Epub 2014 Oct 1. Expert Opin Drug Saf. 2014. PMID: 25270593 Review.
Cited by
-
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System.J Diabetes Sci Technol. 2024 Nov 8:19322968241291512. doi: 10.1177/19322968241291512. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 39517127 Free PMC article. Review.
-
Cosolvent Molecular Dynamics Applied to DPP4, DPP8 and DPP9: Reproduction of Important Binding Features and Use in Inhibitor Design.J Chem Inf Model. 2024 Oct 14;64(19):7650-7665. doi: 10.1021/acs.jcim.4c01167. Epub 2024 Sep 27. J Chem Inf Model. 2024. PMID: 39332821
-
The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension.Clin Hypertens. 2024 Sep 1;30(1):24. doi: 10.1186/s40885-024-00279-4. Clin Hypertens. 2024. PMID: 39217384 Free PMC article. Review.
-
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss.Acta Sci Neurol. 2024 May;7(5):12-18. doi: 10.31080/asne.2024.07.0731. Epub 2024 Apr 19. Acta Sci Neurol. 2024. PMID: 39118673 Free PMC article.
-
Glucagon-Like Peptide Receptor-1 Agonists Used for Medically-Supervised Weight Loss in Patients With Hip and Knee Osteoarthritis: Critical Considerations for the Arthroplasty Surgeon.Arthroplast Today. 2024 Jun 27;27:101327. doi: 10.1016/j.artd.2024.101327. eCollection 2024 Jun. Arthroplast Today. 2024. PMID: 39071832 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
